CAPRICOR THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CAPRICOR THERAPEUTICS, INC. (CAPR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $192.21 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2014-08-14
- CAPRICOR THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-06-30 was $107.66K.
- CAPRICOR THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-03-31 was $84.54K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2014-06-30 | $107.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $192.21K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $84.54K 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $263.59K 10-Q · filed 2014-05-15 | ||
| 2012-12-31 | $332.35K 10-Q · filed 2014-05-15 | ||
| 2011-12-31 | $15.53K 10-Q · filed 2014-05-15 | ||
| 2010-12-31 | $24.16K 10-Q · filed 2014-05-15 | ||
| 2009-12-31 | $8.25K 10-Q · filed 2014-05-15 | ||
| 2008-12-31 | $16.42K 10-Q · filed 2014-05-15 | ||
| 2007-12-31 | $5.82K 10-Q · filed 2014-05-15 | ||
| 2006-12-31 | $10.00K 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |